pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

3,138 catalysts · 4,728 grant · 3,603 8k filing · 2,594 approval · 1,952 device 510k · 1,578 device recall · 1,359 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×type: approval×from 2025-09-02×clear all
type
  • grant4,728
  • 8k filing3,603
  • approval2,594
  • device 510k1,952
  • device recall1,578
  • device pma1,359
device adverse event
1,000
  • earnings585
  • recall544
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Sep 1, 2025

    17
    ›Sep 2, 2025approval362d agoEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalEPYSQLI

    Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION

    full page →EPYSQLI →fda approvals ↗
    ›Sep 3, 2025approval361d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →risankizumab →fda approvals ↗
    ›Sep 3, 2025approval361d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

    full page →risankizumab →fda approvals ↗
    ›Sep 3, 2025approval361d agoVIGAFYDE (VIGABATRIN) — FDA approvalPyros Pharmaceuticals Inc.

    Sponsor: PYROS PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Sep 3, 2025approval361d agoVIGAFYDE (VIGABATRIN) — FDA approvalPyros Pharmaceuticals Inc.

    Sponsor: PYROS PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Sep 3, 2025approval361d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: RUBICON RESEARCH. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Sep 3, 2025approval361d agoRYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalamivantamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →amivantamab →fda approvals ↗
    ›Sep 3, 2025recall361d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    Good Neighbor Pharmacy, Alcohol Prep Pads, Distributed By AmeriSource Bergen, 1 West First Avenue, Conshohocken, PA 19428, Made in China: 100 eaches per box, 30 boxes per case, (3,000 eaches per case), NDC 46122-043-78. — Reason: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    CURAD Alcohol Prep Pads, Sterile, Medium, 2-Ply, Contents: 5 boxes per Carton, 30 Boxes per Case, Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093, USA, Made in India, www.curad.com, 1-800-633-5463, NDC 53329-827-30 — Reason: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoCardinal Health Inc. recall (Cls II)CARDINAL HEALTH INC

    Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01 — Reason: Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    ReliOn, Sterile Alcohol Swabs, Skin Cleanser, 200 Swabs, Distributed by, Walmart, Inc., Bentonville, AR 72716 Walmart: 200 eaches per box, 24 boxes per case (4,800 eaches per case), NDC 49035-814-60. — Reason: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoBaxter Healthcare Corporation recall (Cls II)Baxter Healthcare Corp

    Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60. — Reason: Discoloration — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    Medline Alcohol Prep Pads, 70% Isopropyl Alcohol, 100 Sterile 2-Ply Pads, Single Use Only, Large, www.medline.com, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, 1-800-MEDLINE, NDC 53329-811-30. — Reason: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoLannett Company Inc. recall (Cls II)Lannett Co Inc

    Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37 — Reason: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg. — Status: Completed

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoAmerisource Health Services LLC recall (Cls II)AltrixBio Inc

    Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose] — Reason: CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    RITE AID PHARMACY, first aid alcohol prep pads, DISTRIBUTED BY: RITE AID. 200 NEWBERRY COMMONS, ETTERS, PA 17319, NDC 11822-5156-2. — Reason: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 3, 2025recall361d agoMEDLINE INDUSTRIES, LP - Northfield recall (Cls II)

    H-E-B, inControl, Sterile* Alcohol Pads, CONT. 100 PADS, Packaged in China with components from Taiwan, Elaborado Con Orgullo Y Cuidado PARA H-E-B, San Antonio, TX 78204, NDC 37808-809-09. — Reason: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration. — Status: Ongoing

    full page →fda recalls ↗

    Week of Sep 8, 2025

    23
    ›Sep 9, 2025approval355d agoTEPEZZA (TEPROTUMUMAB-TRBW) — FDA approvalteprotumumab

    Sponsor: HORIZON THERAPEUTICS IRELAND. Form: INJECTABLE. Route: INJECTION

    full page →teprotumumab →fda approvals ↗
    ›Sep 10, 2025approval

    Week of Sep 15, 2025

    10
    ›Sep 15, 2025approval349d agoFLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approvalGlaxoSmithKline LLC

    Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Sep 16, 2025approval
    ← prev
    page 1 of 63
    next →
    354d ago
    KOSELUGO (SELUMETINIB SULFATE) — FDA approvalselumetinib sulfate

    Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

    full page →selumetinib sulfate →fda approvals ↗
    ›Sep 10, 2025approval354d agoKOSELUGO (SELUMETINIB) — FDA approvalselumetinib sulfate

    Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

    full page →selumetinib sulfate →fda approvals ↗
    ›Sep 10, 2025approval354d agoOSENVELT (DENOSUMAB-BMWO) — FDA approvalOSENVELT

    Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION

    full page →OSENVELT →fda approvals ↗
    ›Sep 10, 2025approval354d agoCABOMETYX (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

    Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL

    full page →cabozantinib s-malate →fda approvals ↗
    ›Sep 10, 2025recall354d agoBoothwyn Pharmacy LLC recall (Cls II)Novo Nordisk AS

    Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoDermaRite Industries, LLC recall (Cls I)

    PeriGiene, Health Care Antiseptic, (Chloroxylenol 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-198-08 — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoB BRAUN MEDICAL INC recall (Cls I)B. Braun Medical Inc

    0.9% Sodium Chloride Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7800-09 — Reason: Presence of Particulate Matter. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoDermaRite Industries, LLC recall (Cls I)

    DermaSarra, External Analgesic, (Camphor 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08 — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoBoothwyn Pharmacy LLC recall (Cls III)

    Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496 — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100-count bottles Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1062-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1060-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottles, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1056-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoDermaRite Industries, LLC recall (Cls I)

    DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E (Chloroxylenol 0.2%), packaged in a) 800 ml (27 fl. oz.) bag-n-box (NDC 61924-092-27) and b) 1000ml (34 fl. oz.) bag-n-box (NDC 61924-092-34) , DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    Sulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg, Double Strength, Rx Only, Packaged as a) 100-count bottle, NDC 65162-272-10; b) 500-count bottle, NDC 65162-272-50; Manufactured by: Amneal Pharmaceuticals, Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoDermaRite Industries, LLC recall (Cls I)

    KleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-093-34 — Reason: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoAmneal Pharmaceuticals, LLC recall (Cls II)Amneal Pharmaceuticals, Inc.

    chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1058-1. — Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoBoothwyn Pharmacy LLC recall (Cls II)Novo Nordisk AS

    Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoB BRAUN MEDICAL INC recall (Cls I)B. Braun Medical Inc

    Lactated Ringers's Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7750-07 — Reason: Presence of Particulate Matter — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoIMMUNOCORE, LLC recall (Cls II)Immunocore Holdings plc

    KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026 — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 10, 2025recall354d agoBoothwyn Pharmacy LLC recall (Cls II)Novo Nordisk AS

    Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Sep 11, 2025approval353d agoEPKINLY (EPCORITAMAB-BYSP) — FDA approvalepcoritamab

    Sponsor: GENMAB US, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →epcoritamab →fda approvals ↗
    ›Sep 11, 2025approval353d agoILLUCCIX (GALLIUM GA-68 GOZETOTIDE) — FDA approvalILLUCCIX

    Sponsor: TELIX. Form: POWDER. Route: INTRAVENOUS

    full page →ILLUCCIX →fda approvals ↗
    348d ago
    ACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Sep 16, 2025approval348d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Sep 16, 2025approval348d agoHYMPAVZI (MARSTACIMAB-HNCQ) — FDA approvalmarstacimab

    Sponsor: PFIZER INC. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →marstacimab →fda approvals ↗
    ›Sep 16, 2025approval348d agoAUKELSO (DENOSUMAB-KYQQ) — FDA approvalAUKELSO

    Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION

    full page →AUKELSO →fda approvals ↗
    ›Sep 17, 2025approval347d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Sep 17, 2025approval347d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Sep 17, 2025approval347d agoBKEMV (ECULIZUMAB-AEEB) — FDA approvaleculizumab biosimilar

    Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION

    full page →eculizumab biosimilar →fda approvals ↗
    ›Sep 17, 2025approval347d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Sep 17, 2025approval347d agoAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAMJEVITA

    Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION

    full page →AMJEVITA →fda approvals ↗
    $ABBV255.48-1.03%
    $CAH235.13-1.37%
    $ABBV255.48-1.03%
    $AZN164.52-1.05%
    $AMRX17.54-2.61%
    $AZN164.52-1.05%
    $EXEL55.26-1.50%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $IMCR36.62-0.35%
    $AMRX17.54-2.61%
    $TLX
    $PFE27.96-0.21%
    $HCWB
    $RDHL0.7390+6.64%
    $RDHL0.7390+6.64%
    $AMGN432.42-1.05%
    $AMGN432.42-1.05%